Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 521 participants.

Also called NCT02752828

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 521 participants (enrolled count) (from the registry)
Sponsor
  • Sanofi Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02752828
Other papers using this trial's data
  • Efficacy and safety of insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi 1:1) in Japanese patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic drugs: A randomized, 26-week, open-label, multicentre study: The LixiLan JP-O2 randomized clinical trial Diabetes, obesity & metabolism, 2020-09 DOI, PubMed 32291880

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02752828. Randomized; no masking; primary purpose treatment. Start 2016-05-23 (registry gives no type); primary completion 2018-03-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan
Acronym
LIXILAN JP-O2
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Insulin glargine/lixisenatide (HOE901/AVE0010)
Intervention (Drug)
Insulin glargine (HOE901)
Intervention (Drug)
Oral anti-diabetic drugs
Lead sponsor
Sanofi (class: industry)

Record details

Record id
cardio:ct-nct02752828
Content hash
93dbe874ba7903db5efb7b58ae92bf22f45acfc47f31bc2674a41c1f26323126